| Chad Robins | Chief Executive Officer and Chairman | FY2023 | |
| Harlan Robins, PhD | Chief Scientific Officer | FY2022 | |
| Julie Rubinstein | President and Chief Operating Officer | FY2023 | |
| Susan Bobulsky | Chief Commercial Officer, MRD | FY2024 | |
| Kyle Piskel | Chief Financial Officer | FY2023 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.